I feel very honored to receive this first prize in Kerstin Brismar’s name and hope that it will contribute to us defeating Type 1 diabetes!”, says Johnny Ludvigsson.
Professor Johnny Ludvigsson, senior researcher at Linköping University and founder of the Children’s Diabetes Foundation, is the first to be awarded the Kerstin Brismar Award. Ludvigsson receives the award in recognition of his scientific excellence and his unwavering commitment to improving the lives of children affected by type 1 diabetes.
– “I feel very honored to receive this first award in Kerstin Brismar’s name, and I hope that it will contribute to our defeating Type 1 diabetes!”, says Johnny Ludvigsson.
The Kerstin Brismar Award was launched in January 2025 and will be awarded annually to researchers in translational research, i.e. the transfer of research results from basic research to patient-centered research.
At an award ceremony on November 6, Johnny Ludvigsson will receive the award and also give an award lecture under the heading: “How can we preserve the insulin-producing cells”?
At the ceremony, Professor Per-Ola Carlsson from Uppsala University, Academic University Hospital, will also speak about his groundbreaking research “Transplantation of insulin-producing cells without immunosuppressive drugs”.
Read more about the “Kerstin Brismar Award” on the foundation’s website here.
Motivation of the Prize Committee
”Johnny Ludvigsson is a globally recognized researcher whose lifelong dedication to pediatric diabetes has profoundly shaped the field. His work has primarily focused on type 1 diabetes, with a strong emphasis on understanding its early development and preventing the disease. Through a translational research approach, he has successfully bridged laboratory discoveries and clinical application, building his program on experimental and epidemiological studies as well as clinical observations. As principal investigator for several clinical trials and author of around 700 scientific papers, he has made an exceptional contribution to the global knowledge on type 1 diabetes. His current project, “Efforts to preserve insulin producing cells,” aims to save beta cell function before diagnosis to delay or prevent disease onset, and to intervene after diagnosis to improve treatment outcomes and reduce complications. These studies build on decades of research, supported by extensive registries and biobanks that continue to enable international collaboration. Johnny Ludvigsson receives the KB award in recognition of his scientific excellence and unwavering commitment to improving the lives of children affected by type 1 diabetes through translational studies.”
